Gestational Thyrotoxicosis Associated With Emesis In Early Pregnancy by Ndungu, JR et al.
February 2009 EAST AFRICAN MEDICAL JOURNAL   55
East African Medical Journal Vol. 86 No. 2 February 2009
GESTATIONAL THYROTOXICOSIS ASSOCIATED WITH EMESIS IN EARLY PREGNANCY
J. R. Ndungu, MBChB, MMed, Lecturer, A. Amayo, MBChB, MMed, Senior Lecturer, Department of Human Pathology, 
Z.P. Qureshi, MBChB, MMed, Senior Lecturer, Department of Obstetrics and Gynaecology and C. Sekadde Kigondu, 
BSc, PhD, Associate Professor, Department of Human Pathology, College of Health Sciences, University of Nairobi, 
P. O. Box 19676 - 00202, Nairobi, Kenya, 
Request for reprints to: Dr. J.R. Ndungu, Department of Human Pathogy, College of Health Sciences, University of 
Nairobi, P. O. Box 19676 - 00202, Nairobi, Kenya 
GESTATIONAL THYROTOXICOSIS ASSOCIATED WITH EMESIS 
IN EARLY PREGNANCY
J. R. NDUNGU, A. AMAYO,  Z.P. QURESHI and C. SEKADDE KIGONDU
ABSTRACT
Objectives: To determine the thyroid profile and the prevalence of gestational 
thyrotoxicosis among women with emesis during early pregnancy. 
Design: A descriptive cross - sectional study. 
Setting: Kenyatta National Hospital acute gynaecology ward and the ante-natal 
clinic. 
Subjects: Seventy two women presenting with emesis up to 16 weeks gestation.
Main outcome measures: The levels of FT3, FT4, TSH and β-hCG during the first 16 
weeks of gestation. Correlation between the thyroid hormones and β-hCG as well as 
the severity of vomiting was also done. 
Results: The point prevalence of gestational thyrotoxicosis was 8.3%. There was a 
significant positive correlation between β-hCG levels and FT3 and FT4 (P-values 
< 0.05), and a significant negative correlation between β-hCG and TSH (P < 0.05). 
Correlation between the severity of vomiting and the thyroid hormones as well as 
β-hCG was not statistically significant. Patients' age ranged from 14-38 years (median 
26). Majority of the women studied were at a gestation of 8 to 11 weeks (38.9%). Most 
patients (84.7%) had one to five episodes of vomiting per day. Peak β-hCG was at 12 
- 15 weeks gestation. 
Conclusions: Thyrotoxicosis does occur among women with emesis in pregnancy in 
this set-up. Screening for it may be beneficial to such women and also those with high 
serum β-hCG levels above the median for the gestational age. 
INTRODUCTION
Maternal hyperthyroidism may have deleterious 
effects on the outcome of pregnancy. The most 
common cause of hyperthyroidism in women of 
child-bearing age (both pregnant and non-pregnant 
women) is Graves’ disease. In recent years, another 
cause that has been characterised results from direct 
stimulatory effects of β-hCG on the thyroid. This can 
induce thyrotoxicosis transiently during the first 
half of gestation, and its prevalence in pregnancy 
much higher than that of Graves' disease, although 
it has usually less severe clinical manifestations. 
The syndrome, referred to as gestational transient 
thyrotoxicosis (GTT), differs from Graves' disease in 
that it is not of autoimmune origin, and the course, 
foetal risks, and management and follow-up of both 
entities are different (1). 
 The precise pathogenic mechanisms underlying 
GTT are still not fully understood. It is thought 
that abnormal molecular variants of β-hCG, with a 
prolonged half life, are produced in these situations 
explaining sustained high circulating β-hCG levels, 
or β-hCG variants with a more potent thyrotropic 
activity (2). It has also been hypothesised that a 
dysregulation of β-hCG production may transiently 
take place (3). A quantitative direct effect of elevated 
β-hCG to stimulate the thyroid gland may presumably 
be sufficient to explain GTT in most pregnant women, 
provided that β-hCG values remain above 75,000-
100,000 U/L for a sufficient period of time. GTT is 
directly related to both the amplitude and duration 
of peak β-hCG. Whatever the final explanation, the 
effects of β-hCG to stimulate the thyroid gland can 
best be explained by the marked homology that 
exists between the β-hCG and TSH molecules, as 
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well as between the LH/β-hCG and TSH receptors 
(4,5). Thus, GTT can be considered an example of an 
endocrine "spillover "syndrome, a concept based on 
the molecular mimicry between hormone ligands 
and their receptors (5-7). 
 An unresolved question is whether the thyroid 
gland is the passive bystander (or the victim) of 
abnormal thyrotropic activity of β-hCG in GTT, or 
whether the gland itself, through variable degrees of 
sensitivity of the TSH receptor, may play an active 
role in its responsiveness to the action of β-hCG. 
So far, only one example has been reported with a 
substantially increased sensitivity of the TSH receptor 
to the stimulatory effect of β-hCG, due to a single 
mutation in the extracellular domain of the TSH 
receptor (KI83R) (8). The mutant TSH receptor was 
more sensitive than the wild-type receptor to β-hCG, 
thus accounting for recurrent thyrotoxicosis during 
pregnancy in the presence of normal β-hCG levels. 
This finding raises the possibility that some women 
who develop GTT may have an abnormality at the 
level of the thyroid follicular cell. 
 GTT is often associated with nausea (morning 
sickness), increased vomiting and hyperemesis 
gravidarum, a severe condition requiring 
hospitalisation and drastic treatment (9). Studies 
have established the correlation between severity of 
emesis and abnormalities of thyroid function. 
MATERIALS AND METHODS
This was a prospective study conducted at Kenyatta 
National Hospital, Nairobi. Serum samples were 
obtained from 72 women presenting with emesis up 
to 16 weeks gestation. Permission was obtained from 
the KNH ethical committee and informed written 
consent was obtained from the participants. Patients 
who were known to have thyroid disorders before 
pregnancy and those with features of other underlying 
diseases were excluded. 
 Serum TSH, FT3, FT4 and β-hCG were estimated 
by immunoassay on an Abbott IMX machine. Samples 
were run in batches and three levels of controls 
(low, medium and high) were included in each 
run to validate the results. Validated manufacturer 
recommended reference values for T5H, FT3, FT4 and 
β-hCG were used to interpret the hormone values. 
Gestational thyrotoxicosis was defined as elevated 
FT4 and FT3 with lowTSH. 
 Data analysis was performed using SPSS (version 
12.0). Logarithmic transformation was performed for 
β-hCG as it did not conform to a gaussian distribution. 
Correlations between continuous variables were 
assessed using Pearsons correlation coefficients. 
A P-value of < 0.05 was considered statistically 
significant. 
RESULTS
A total of 72 women with emesis during early 
pregnancy were studied. Their ages ranged from 
fourteen to thirty eight years with an average of 
twenty five years. The majority of the women were 
in the age group 24 - 28 years. Parity ranged from 
0+0 to 4+4. 
 Most of the patients (84.7%) had moderate 
vomiting (one to five episodes of vomiting per day). 
The thyroid hormone levels were classified into low, 
normal or high based on the reference values. Normal 
thyroid profile values were found in most patients. 
There were six patients with elevated FT3 and /or 
FT4 levels with low TSH giving a point prevalence of 
gestational thyrotoxicosis of 8.3% in this study. Five 
(6.9%) patients had high FT3 levels alone. Four (5.6%) of 
those with high FT3 levels also had high FT4 levels with 
two patients having either high FT3 levels or high FT4 
levels. All those with high FT3 and /or high FT4 levels 
had low TSH levels. The two patients with low FT4 had 
normal TSH levels while one patient with a high TSH 
levels had a normal FT4/FT3 levels. One patient with 
low FT3 had accompanying low TSH while the other 
patient with low FT3 had normal TSH level. Nineteen 
patients (26.4%) had low TSH levels (Table 1). 
 The β-hCG level among the 72 study subjects 
ranged from 1,664 miu/ml to 286,628 miu/ml with a 
mean of 121,740 miu/ml. The peak β-hCG was at 12 
- 15 weeks gestation (mean 283,136 miu/ml) followed 
by a decline.
Table 1
Thyroid hormone levels in patients with emesis during 
pregnancy (n=72) 
Hormone level No.  (%)
FT3 (pg/dl)
  Low 2 2.8
  Normal 65 90.3
  High 5 6.9
FT4 (pg/dl)
  Low 2 2.8
  Normal 65 90.3
  High 5 6.9
TSH (μiu/ml)
  Low 19 26.4
  Normal 52 72.2
  High 1 1.4
All those with high FT3 and/or FT4 levels had β-hCG 
levels above the mean value for the study subjects 
and also above the reference ranges for the gestation 
(Table 2). 
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 There was a significant positive correlation 
between β-hCG levels and FT4 levels with a P-value 
of 0.025. Those with high FT4 had corresponding 
higher levels of β-hCG compared to those with either 
low or normal FT4. 
 There was a significant positive correlation 
between β-hCG levels and FT3 levels with a P -value 
of 0.023. 
Figure 1
Correlation between the β-HCG levels and the TSH 
levels in patients with emesis
There was a significant negative correlation between 
β-hCG and the TSH levels (P-value < 0.05) (Figure 
1). The correlation between the severity of vomiting 
and the levels of FT3, FT4, TSH and β-hCG was not 
significant (p-value> 0.05). 
DISCUSSION
The prevalence of gestational thyrotoxicosis in this 
study was found to be 8.3 %. Gestational thyrotoxicosis 
was defined as the presence of an elevated FT4 or 
FT3 or both with a corresponding depressed level of 
TSH in a patient with emesis during pregnancy. This 
prevalence of gestational thyrotoxicosis in this study 
corresponds with other studies done in other regions 
of the world where the prevalence of gestational 
thyrotoxicosis was found to vary from 0.3% in Japan 
to 11% in Hong Kong (6). 
 There were discordances between TSH and 
the free thyroid hormones in this study the most 
common being low TSH with normal FT3 and 
FT4 which was found in fourteen (19.4%) patients. 
The possible explanations to this are sub-clinical 
thyrotoxicosis or resolving thyrotoxicosis. Subclinical 
thyrotoxicosis is defined as a low serum thyrotrophin 
(TSH) concentration in a patient with normal serum 
free thyroxine (FT4) and free triiodothyronine 
(FT3) concentrations. The secretion of TSH may be 
suppressed even in the presence of normal serum 
thyroid hormone levels. This reflects the highly 
sensitive response that the pituitary gland mounts to 
minor changes in serum FT4 and FT3 concentrations 
(10). 
 Studies have revealed that, in some cases the 
serum TSH may remain partially suppressed for 
several weeks after the FT 4 and FT3 have reverted to 
normal in patients who had gestational thyrotoxicosis 
previously (3, 11, 12). Other studies showed that the 
serum TSH might be transiently suppressed in 10-
20% of euthyroid women at the time of peak β-hCG 
levels (11). 
 Three patients had either low FT3 or FT4 levels 
with normal TSH values. These could possibly be 
cases of euthyroid sick syndrome where systemic 
non thyroidal diseases e.g. severe vomiting during 
pregnancy, infections or even toxaemia during 
pregnancy affect the free thyroid hormones. In this 
study all the patients had emesis some of them severe 
emesis (15.3%) and this could have had effects on the 
thyroid hormones. Euthyroid sick syndrome can be 
described as abnormal findings on thyroid function 
tests that occur in the setting of a non thyroidal illness 
without pre-existing hypothalamic-pituitary and 
thyroid gland dysfunction. After recovery from non 
thyroidal illness, these thyroid function test result 
abnormalities should be completely reversible. 
Table 2
TSH, ß-HCG and the gestation of the subjects with gestational thyrotoxicosis 
FT3(pg/ml) FT4(ng/dl) TSH(µiu/ml) ß-HCG (miu/ml) Gestation
1.68 - 3.54 0.71 - 1.85 0.47 - 5.0 11,500-137,000 (Weeks)   
27.24 6.0 0.01 268,188 10
3.74 1.77 0.13 274,808 8
0.88 3.31 0.05 221,172 11
22.06 5.90 0.00 174,400 13
8.55 2.74 0.11 279,600 16
4.66 2.35 0.16 142,560 9
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 The one patient with high TSH levels had normal 
FT3 and FT4 levels. This could probably be cases of 
early primary hypothyroidism. Hypothyroidism 
occurs during pregnancy relatively frequently. 
A nation-wide US survey showed that 4.6% of 
the population aged 12 years old and older had 
hypothyroidism and that 4.3% of all women 
suffered from thyroid disease or were taking thyroid 
medication. Routine prenatal screening showed that 
2.2% of pregnant women in their second trimester 
had thyroid stimulating hormone (TSH) levels at or 
above 6 µIU/L (12). 
 There was one patient who had low TSH with low 
free thyroid hormones. Despite the fact that this was 
considered to be a case of secondary hypothyroidism 
further evaluation of the other anterior pituitary 
hormones needed to be done to confirm pituitary 
gland pathology. In this study a significant positive 
correlation was found between β-hCG and FT4/FT3 
levels (P-values 0.025 and 0.023 for FT4 and FT3 
respectively). A significant negative correlation 
between TSH and β-hCG levels was found (p-value 
0.025). These findings are similar to those of Yeo et al 
(13) who investigated the prevalence of gestational 
thyrotoxicosis in Asian women in Singapore and 
found-out that the total and free β-hCG correlated 
negatively with TSH (P < 0.0001 and P < 0.0001, 
respectively), positively with FT4 (P < 0.001 and P < 
0.001) and FT3 (P < 0.001 and P < 0.01). 
 Similarly the positive correlation between the 
thyroid hormones and the β-hCG levels during 
pregnancy in this study corresponds with other 
studies which have shown that normal women may 
develop gestational transient thyrotoxicosis when 
they have abnormally elevated peak β-hCG levels 
and when these are sustained during an unusually 
prolonged period (4, 12). 
 Some reports have indicated that up to two thirds 
of pregnant women presenting with hyperemesis have 
biochemical features suggesting hyperthyroidism 
(with an increased free T4 and suppressed TSH) 
and that the more seriously ill among these women 
also have an elevation in serum free T3 (14). Some 
investigators showed that the severity of emesis 
correlated with the levels of free T4 and β-hCG (and 
TSH suppression) (15). 
 In this study however, there was no significant 
correlation between the severity of vomiting and 
the levels of FT3, FT4 , TSH and β-HCG. This lack 
of correlation may be explained by the fact that only 
a few of those studied (15.3%) had hyperemesis 
gravidarum the rest having relatively mild emesis 
during pregnancy. 
 From this study it was shown that thyrotoxicosis 
does occur among women with emesis in pregnancy in 
this set-up. Screening protocol for it may be beneficial 
to such women. 
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